Owens & Minor, Inc. (OMI)
NYSE: OMI · Real-Time Price · USD
5.34
+0.06 (1.14%)
Oct 29, 2025, 1:41 PM EDT - Market open
Owens & Minor Revenue
Owens & Minor had revenue of $681.92M in the quarter ending June 30, 2025, with 3.26% growth. This brings the company's revenue in the last twelve months to $10.76B, up 64.35% year-over-year. In the year 2024, Owens & Minor had annual revenue of $10.70B with 3.55% growth.
Revenue (ttm)
$10.76B
Revenue Growth
+64.35%
P/S Ratio
0.04
Revenue / Employee
$463,726
Employees
23,200
Market Cap
412.48M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 10.70B | 366.92M | 3.55% |
| Dec 31, 2023 | 10.33B | 378.49M | 3.80% |
| Dec 31, 2022 | 9.96B | 170.16M | 1.74% |
| Dec 31, 2021 | 9.79B | 1.31B | 15.39% |
| Dec 31, 2020 | 8.48B | -730.76M | -7.93% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 63.62B |
| AbbVie | 58.33B |
| AstraZeneca | 56.50B |
| Novartis AG | 56.37B |
| Eli Lilly and Company | 53.26B |
| Novo Nordisk | 49.11B |
OMI News
- 13 days ago - Owens & Minor Announces Date and Time Change of Third Quarter 2025 Financial Results and Conference Call - Business Wire
- 21 days ago - PLATINUM EQUITY TO ACQUIRE PRODUCTS & HEALTHCARE SERVICES BUSINESS FROM OWENS & MINOR - PRNewsWire
- 21 days ago - Owens & Minor Announces Definitive Agreement to Divest Products & Healthcare Services Segment to Platinum Equity for $375mm in Cash and a Retained Equity Stake - Business Wire
- 6 weeks ago - Apria and Byram Join New Optum Preferred DME Network - Business Wire
- 7 weeks ago - AppLovin, Robinhood Markets and Emcor Group Set to Join S&P 500; Others to Join S&P 100, S&P MidCap 400 and S&P SmallCap 600 - PRNewsWire
- 2 months ago - Owens & Minor Analysts Boost Their Forecasts After Q2 Results - Benzinga
- 2 months ago - Owens & Minor: An Extreme Reached Amid Disastrous Results (Rating Upgrade) - Seeking Alpha
- 2 months ago - Owens & Minor, Inc. (OMI) Q2 2025 Earnings Call Transcript - Seeking Alpha